XBiotech Inc.
XBIT
$2.69
-$0.26-8.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.09% | -8.76% | -2.26% | -19.15% | -26.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.23% | 13.17% | 16.22% | 10.50% | -2.57% |
| Operating Income | -13.23% | -14.09% | -22.81% | -21.98% | -8.76% |
| Income Before Tax | -58.60% | -47.48% | -36.97% | 1.77% | 27.61% |
| Income Tax Expenses | -113.17% | -109.78% | -93.06% | -8.68% | 135.32% |
| Earnings from Continuing Operations | -56.90% | -41.22% | -23.18% | 1.85% | 25.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.90% | -41.22% | -23.18% | 1.85% | 25.36% |
| EBIT | -13.23% | -14.09% | -22.81% | -21.98% | -8.76% |
| EBITDA | -13.87% | -14.83% | -25.21% | -25.58% | -12.20% |
| EPS Basic | -56.79% | -41.16% | -23.15% | 1.85% | 25.34% |
| Normalized Basic EPS | -58.51% | -47.42% | -36.94% | 1.78% | 27.61% |
| EPS Diluted | -56.00% | -41.46% | -23.44% | 1.26% | 24.79% |
| Normalized Diluted EPS | -58.51% | -47.42% | -36.94% | 1.78% | 27.61% |
| Average Basic Shares Outstanding | 0.07% | 0.05% | 0.02% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.07% | 0.05% | 0.02% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
